Membranous nephropathy after multiple Hymenoptera stings: a case report.

Hymenoptera sting Membranous nephropathy Nephrotic syndrome

Journal

CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244

Informations de publication

Date de publication:
18 Nov 2023
Historique:
received: 27 07 2023
accepted: 25 10 2023
medline: 19 11 2023
pubmed: 19 11 2023
entrez: 18 11 2023
Statut: aheadofprint

Résumé

An association between Hymenoptera (bee and wasp) stings and nephrotic syndrome has been rarely reported. We report a case of nephrotic syndrome after multiple Hymenoptera stings, and membranous nephropathy was later diagnosed by a kidney biopsy. The patient was a 79-year-old woman who was stung by Hymenoptera at seven sites on her body. A weight gain of 3.7 kg was observed in the patient at 1 week after being stung, and she had considerable edema in both lower extremities. A urine protein concentration of 14.8 g/g creatinine and a serum albumin concentration of 1.7 g/dL led to the diagnosis of nephrotic syndrome. A percutaneous kidney biopsy 8 days after the Hymenoptera stings showed stage I membranous nephropathy. She was in complete remission 1 week after the administration of oral prednisolone 40 mg/day, which was started 14 days after Hymenoptera stings, and had no relapse of nephrotic syndrome. To the best of our knowledge, this is the first report of biopsy-proven membranous nephropathy caused by Hymenoptera stings.

Identifiants

pubmed: 37980317
doi: 10.1007/s13730-023-00834-2
pii: 10.1007/s13730-023-00834-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Japanese Society of Nephrology.

Références

Hoffman DR. Hymenoptera venom allergens. Clin Rev Allergy Immunol. 2006;30:109–28. https://doi.org/10.1385/CRIAI:30:2:109 .
doi: 10.1385/CRIAI:30:2:109 pubmed: 16645223
Vetter RS, Visscher PK, Camazine S. Mass envenomations by honey bees and wasps. West J Med. 1999;170:223–7 PMID: 10344177.
pubmed: 10344177 pmcid: 1305553
Rytand DA. Onset of the nephrotic syndrome during a reaction to bee sting. Stanford Med Bull. 1955;13:224–33 (PMID: 14386174).
pubmed: 14386174
Venters HD, Vernier RL, Worthen HGGR. Bee sting nephrosis: a study of the immunopathologic mechanisms. Am J Dis Child. 1961;102:688–9.
Olivero JJ, Ayus JC, Eknoyan G. Nephrotic syndrome developing after bee stings. South Med J. 1981;74:82–3. https://doi.org/10.1097/00007611-198101000-00030 .
doi: 10.1097/00007611-198101000-00030 pubmed: 7455752
Révai T, Harmos G. Simvastatin treatment in nephrotic syndrome associated with a bee sting. J R Soc Med. 1999;92:23–4. https://doi.org/10.1177/014107689909200110 .
doi: 10.1177/014107689909200110 pubmed: 10319035 pmcid: 1297036
Zaman F, Saccaro S, Latif S, Atray N, Abreo K. Minimal change glomerulonephritis following a wasp sting. Am J Nephrol. 2001;21:486–9. https://doi.org/10.1159/000046653 .
doi: 10.1159/000046653 pubmed: 11799266
Humeda YS, Clapp WL, Humeda H. Minimal change disease after multiple wasp stings. Clin Nephrol Case–Stud. 2022;10:16–20. https://doi.org/10.5414/cncs110369 .
doi: 10.5414/cncs110369 pubmed: 35096510 pmcid: 8795984
Taber TE, King LH, Aust CH. Bee sting nephropathy in a transplant patient. Indiana Med. 1986;79:778–9 (PMID: 3534070).
pubmed: 3534070
Sensirivatana R, Sukvichai P, Futrakul P. Nephrotic syndrome following a bee sting. J Med Assoc Thail. 1984;67:525–8 (PMID: 6520578).
Tauk B, Hachem H, Bastani B. Nephrotic syndrome with mesangial proliferative glomerulonephritis induced by multiple wasp stings. Am J Nephrol. 1999;19:70–2. https://doi.org/10.1159/000013429 .
doi: 10.1159/000013429 pubmed: 10085454
Bobart SA, Tehranian S, Sethi S, Alexander MP, Nasr SH, Moura Marta C, et al. A target antigen–based approach to the classification of membranous nephropathy. Mayo Clin Proc. 2021;96:577–91. https://doi.org/10.1016/j.mayocp.2020.11.028 .
doi: 10.1016/j.mayocp.2020.11.028 pubmed: 33673911
Ren S, Wu C, Zhang Y, Wang AY, Li G, Wang L, et al. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy : a systematic review and meta- analysis of THSD7A in IMN. Ren Fail. 2018;40:306–13. https://doi.org/10.1080/0886022X.2018.1456457 .
doi: 10.1080/0886022X.2018.1456457 pubmed: 29623759 pmcid: 6014291
Sethi S, Debiec H, Madden B, Charlesworth MC, Morelle J, Gross LA, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int. 2020;97:163–74. https://doi.org/10.1016/j.kint.2019.09.014 .
doi: 10.1016/j.kint.2019.09.014 pubmed: 31901340
Sethi S, Madden BJ, Debiec H, Cristine Charlesworth M, Gross L, Ravindran A, et al. Exostosin 1/exostosin 2–associated membranous nephropathy. J Am Soc Nephrol. 2019;30:1123–36. https://doi.org/10.1681/ASN.2018080852 .
doi: 10.1681/ASN.2018080852 pubmed: 31061139 pmcid: 6551791
Sethi S, Debiec H, Madden B, Vivarelli M, Charlesworth MC, Ravindran A, et al. Semaphorin 3B–associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney Int. 2020;98:1253–64. https://doi.org/10.1016/j.kint.2020.05.030 .
doi: 10.1016/j.kint.2020.05.030 pubmed: 32534052
Sethi S, Madden B, Debiec H, Morelle J, Charlesworth MC, Gross L, et al. Protocadherin 7–associated membranous nephropathy. J Am Soc Nephrol. 2021;32:1249–61. https://doi.org/10.1681/ASN.2020081165 .
doi: 10.1681/ASN.2020081165 pubmed: 33833079 pmcid: 8259689
Caza TN, Hassen SI, Kuperman M, Sharma SG, Dvanajscak Z, Arthur J, et al. Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney Int. 2021;100:171–81. https://doi.org/10.1016/j.kint.2020.09.016 .
doi: 10.1016/j.kint.2020.09.016 pubmed: 33045259
Bajcsi D, Bitó L, Turkevi-Nagy S, Nyári T, Kemény É, Légrády P, et al. The value of PLA2R antigen and IgG subclass staining relative to anti-PLA2R seropositivity in the differential diagnosis of membranous nephropathy. BMC Nephrol. 2023;24:230. https://doi.org/10.1186/s12882-023-03273-4 .
doi: 10.1186/s12882-023-03273-4 pubmed: 37550626 pmcid: 10408061
Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21. https://doi.org/10.1056/NEJMoa0810457 .
doi: 10.1056/NEJMoa0810457 pubmed: 19571279 pmcid: 2762083
Ishizaki J, Suzuki N, Higashino KI, Yokota Y, Ono T, Kawamoto K, et al. Cloning and characterization of novel mouse and human secretory phospholipase A2S. J Biol Chem. 1999;274:24973–9. https://doi.org/10.1074/jbc.274.35.24973 .
doi: 10.1074/jbc.274.35.24973 pubmed: 10455175
Hossen MS, Shapla UM, Gan SH, Khalil MI. Impact of bee venom enzymes on diseases and immune responses. Molecules. 2017;22:1–16. https://doi.org/10.3390/molecules22010025 .
doi: 10.3390/molecules22010025
Ardalan MR, Ghafari A, Hamzavi F, Nasri H, Baradaran B, Majidi J, et al. Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: a report from Iranian population. J Nephropathol. 2013;2:241–8. https://doi.org/10.12860/JNP.2013.38 .
doi: 10.12860/JNP.2013.38 pubmed: 24475456 pmcid: 3891130
Debiec H, Hanoy M, Francois A, Guerrot D, Ferlicot S, Johanet C, et al. Recurrent membranous nephropathy in an allograft caused by IgG3k targeting the PLA2 receptor. J Am Soc Nephrol. 2012;23:1949–54. https://doi.org/10.1681/ASN.2012060577 .
doi: 10.1681/ASN.2012060577 pubmed: 23123401 pmcid: 3507371
Kudose S, Santoriello D, Debiec H, Canetta PA, Bomback AS, Stokes MB, et al. The clinicopathologic spectrum of segmental membranous glomerulopathy. Kidney Int. 2021;99:247–55. https://doi.org/10.1016/j.kint.2020.06.014 .
doi: 10.1016/j.kint.2020.06.014 pubmed: 32599086

Auteurs

Kenichi Morii (K)

Department of Nephrology, Ichiyokai Harada Hospital, 7-10 Kairoyamacho, Saeki-ku, Hiroshima, Japan.
Department of Kidney Disease and Community Medicine, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.

Toshiki Doi (T)

Department of Nephrology, Ichiyokai Harada Hospital, 7-10 Kairoyamacho, Saeki-ku, Hiroshima, Japan. doitoshi@hiroshima-u.ac.jp.
Department of Kidney Disease and Community Medicine, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan. doitoshi@hiroshima-u.ac.jp.

Yoshio Yuba (Y)

Department of Nephrology, Ichiyokai Harada Hospital, 7-10 Kairoyamacho, Saeki-ku, Hiroshima, Japan.

Aiko Okubo (A)

Department of Nephrology, Ichiyokai Harada Hospital, 7-10 Kairoyamacho, Saeki-ku, Hiroshima, Japan.

Kazuomi Yamashita (K)

Department of Nephrology, Ichiyokai Harada Hospital, 7-10 Kairoyamacho, Saeki-ku, Hiroshima, Japan.

Sonoo Mizuiri (S)

Department of Nephrology, Ichiyokai Harada Hospital, 7-10 Kairoyamacho, Saeki-ku, Hiroshima, Japan.

Yoshiko Nishizawa (Y)

Department of Nephrology, Ichiyokai Harada Hospital, 7-10 Kairoyamacho, Saeki-ku, Hiroshima, Japan.

Kenichiro Shigemoto (K)

Department of Nephrology, Ichiyokai Harada Hospital, 7-10 Kairoyamacho, Saeki-ku, Hiroshima, Japan.

Akira Shimizu (A)

Department of Analytic Human Pathology, Nippon Medical School, 1-25-16 Nezu, Bunkyo-ku, Tokyo, Japan.

Takao Masaki (T)

Department of Nephrology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.

Classifications MeSH